Genetic basis of remitting sarcoidosis: Triumph of the trimolecular complex?

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 4, 2002, Pages 391-395

  Moller, David R ^a   Chen, Edward S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036787845     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0164PS     Document Type: Review

References (59)

1. Rybicki, B. A., M. C. Iannuzzi, M. M. Frederick, B. W. Thompson, M. D. Rossman, E. A. Bresnitz, M. L. Terrin, D. R. Moller, J. Barnard, R. P. Baughman, L. DePalo, G. Hunninghake, C. Johns, M. A. Judson, G. L. Knatterud, G. McLennan, L. S. Newman, D. L. Rabin, C. Rose, A. S. Teirstein, S. E. Weinberger, H. Yeager, and R. Cherniack. 2001. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am. J. Respir. Crit. Care Med. 164:2085-2091.
2. Rybicki, B. A., D. Harrington, M. Major, M. Simoff, J. Popovich, Jr., M. Maliarik, and M. C. Iannuzzi. 1996. Heterogeneity of familial risk in sarcoidosis. Genet. Epidemiol. 13:23-33.
3. Robinson, J., M. J. Waller, P. Parham, J. G. Bodmer, and S. G. Marsh. 2001. IMGT/HLA Database - a sequence database for the human major histocompatibility complex. Nucleic Acids Res. 29:210-213.
4. Wang, J. H., and E. L. Reinherz. 2002. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol. Immunol. 38:1039-1049.
5. Appella, E., E. A. Padlan, and D. F. Hunt. 1995. Analysis of the structure of naturally processed peptides bound by Class I and Class II major histocompatibility complex molecules. EXS 73:105-119.
6. Brachet, V., G. Pehau-Arnaudet, C. Desaymard, G. Raposo, and S. Amigorena. 1999. Early endosomes are required for major histocompatibiity complex Class II transport to peptide-loading compartments. Mol. Biol. Cell 10;9:2891-904.
7. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex Class II proteins. J. Exp. Med. 191:1513-1524.
8. Ramachandra, L., and C. V. Harding. 2000. Phagosomes acquire nascent and recycling Class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. J. Immunol. 164:5103-5112.
9. Arnold, P. Y., and M. D. Mannie. 1999. Vesicles bearing MHC Class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. Eur. J. Immunol. 29:1363-1373.
10. Bromley, S. K., W. R. Burack, K. G. Johnson, K. Somersalo, T. N. Sims, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19:375-396.
11. Schwartz, J. C., X. Zhang, S. G. Nathenson, and S. C. Almo. 2002. Structural mechanisms of costimulation. Nat. Immunol. 3:427-434.
12. Martinetti, M., M. Luisetti, and M. Cuccia. 2002. HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc. Diffuse Lung Dis. 19:83-95.
13. Niimi, T., H. Tomita, S. Sato, H. Kawaguchi, K. Akita, H. Maeda, Y. Sugiura, and R. Ueda. 1999. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am. J. Respir. Crit. Care Med. 160:1107-1109.
14. Pietinalho, A., K. Furuya, E. Yamaguchi, Y. Kawakami, and O. Selroos. 1999. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur. Respir. J. 13:723-726.
15. Foley, P. J., C. G. Mullighan, D. S. McGrath, P. Pantelidis, S. Marshall, P. A. Lympany, K. I. Welsh, and R. M. du Bois. 2000. Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur. J. Clin. Invest. 30:549-552.
16. Maliarik, M. J., K. M. Chen, R. G. Sheffer, B. A. Rybicki, M. L. Major, J. Popovich, Jr., and M. C. Iannuzzi. 2000. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 22:672-675.
17. Hutyrova, B., P. Pantelidis, J. Drabek, M. Zurkova, V. Kolek, K. Lenhart, K. I. Welsh, R. M. Du Bois, and M. Petrek. 2002. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165:148-151.
18. Schurmann, M., P. Reichel, B. Muller-Myhsok, M Schlaak, J. Muller-Quernheim, and E. Schwinger. 2001. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med. 164:840-846.
19. Singer, D. S., E. Mozes, S. Kirshner, and L. D. Kohn. 1997. Role of MHC Class I molecules in autoimmune disease. Crit. Rev. Immunol. 17;5-6:463-468.
20. McDevitt, H. O. 1998. The role of MHC Class II molecules in susceptibility and resistance to autoimmunity. Curr. Opin. Immunol. 10:677-681.
21. Abraham, R. S., and C. S. David. 2000. Identification of HLA-Class-II-restricted epitopes of autoantigens in transgenic mice. Curr. Opin. Immunol. 12:122-129.
22. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059-1075.
23. Chao, C. C., H. K. Sytwu, E. L. Chen, J. Toma, and H. O. McDevitt. 1999. The role of MHC Class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Proc. Natl. Acad. Sci. USA 96:9299-9304.
24. Rubin, R. L., and A. Kretz-Rommel. 2001. A nondeletional mechanism for central T-cell tolerance. Crit. Rev. Immunol. 21:1-3:29-40.
25. Hanson, M. S., M. Cetkovic-Cvrlje, V. K. Ramiya, M. A. Atkinson, N. K. Maclaren, B. Singh, J. F. Elliott, D. V. Serreze, and E. H. Leiter. 1996. Quantitative thresholds of MHC Class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1279-1287.
26. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291-297.
27. Scott, B., R. Liblau, S. Degermann, L. A. Marconi, L. Ogata, A. J. Caton, H. O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-83.
28. Verdaguer, J., A. Amrani, B. Anderson, D. Schmidt, and P. Santamaria. 1999. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity. J. Immunol. 162:4614-4626.
29. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311-318.
30. Müller-Quernheim, J. 1998. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur. Respir. J. 12:716-738.
31. Moller, D. R. 1998. Involvement of T cells and alterations in T cell receptors in sarcoidosis. Semin. Respir. Infect. 13:174-183.
32. Grunewald, J., C. H. Janson, A. Eklund, M. Ohm, O. Olerup, U. Persson, and H. Wigzell. 1992. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur. J. Immunol. 22:129-135.
33. Forman, J. D., J. T. Klein, R. F. Silver, M. C. Liu, B. M. Greenlee, and D. R. Moller. 1994. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J. Clin. Invest. 94:1533-1542.
34. Forrester, J. M., Y. Wang, N. Ricalton, J. E. Fitzgerald, J. Loveless, L. S. Newman, T. E. King, and B. L. Kotzin. 1994. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J. Immunol. 153:4291-4302.
35. Klein, J. T., T. D. Horn, J. D. Forman, R. F. Silver, A. S. Teirstein, and D. R. Moller. 1995. Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J. Immunol. 154:1450-1460.
36. Moller, D. R. 1999. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 16:24-31.
37. Agostini, C., F. Adami, and G. Semenzato. 2000. New pathogenetic insights into the sarcoid granuloma. Curr. Opin. Rheumatol. 12:71-76.
38. Moller, D. R., J. D. Forman, M. C. Liu, P. W. Noble, B. M. Greenlee, P. Vyas, D. A. Holden, J. M. Forrester, A. Lazarus, M. Wysocka, G. Trinchieri, and C. Karp. 1996. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156:4952-4960.
39. Greene, C. M., G. Meachery, C. C. Taggart, C. P. Rooney, R. Coakley, S. J. O'Neill, and N. G. McElvaney. 2000. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J. Immunol. 165:4718-4724.
40. Rogge, L., A. Papi, D. H. Presky, M. Biffi, L. J. Minetti, D. Miotto, C. Agostini, G. Semenzato, L. M. Fabbri, and F. Sinigaglia. 1999. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J. Immunol. 162:3926-3932.
41. Baughman, R. P., S. A. Strohofer, J. Buchsbaum, and E. E. Lower. 1990. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J. Lab. Clin. Med. 115:36-42.
42. Selroos, O., M. Klockars, R. Kekomaki, K. Pentinen, P. Lindstrom, and O. Wager. 1980. Circulating immune complexes in sarcoidosis. J. Clin. Lab. Immunol. 3:129-132.
43. Gardner, J., H. G. Kennedy, A. Hamblin, and E. Jones. 1984. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 39:19-22.
44. Ina, Y., K. Takada, M. Yamamoto, M. Morishita, Y. Senda, and Y. Torii. 1989. HLA and sarcoidosis in the Japanese. Chest 95:1257-1261.
45. Ishihara, M., S. Ohno, T. Ishida, H. Ando, T. Naruse, Y. Nose, and H. Inoko. 1994. Molecular genetic studies of HLA Class II alleles in sarcoidosis. Tissue Antigens 43:238-241.
46. Martinetti, M., C. Tinelli, V. Kolek, M. Cuccia, L. Salvaneschi, L. Pasturenzi, G. Semenzato, A. Cipriani, A. Bartova, and M. Luisetti. 1995. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am. J. Respir. Crit. Care Med. 152:557-564.
47. Berlin, M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156:1601-1605.
48. Swider, C., L. Schnittger, K. Bogunia-Kubik, J. Gerdes, H. Flad, A. Lange, and U. Seitzer. 1999. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur. Cytokine Netw. 10:143-146.
49. Bogunia-Kubik, K., J. Tomeczko, K. Suchnicki, and A. Lange. 2001. HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57:87-90.
50. Foley, P. J., D. S. McGrath, E. Puscinska, M. Petrek, V. Kolek, J. Drabek, P. A. Lympany, P. Pantelidis, K. I. Welsh, J. Zielinski, and R. M. du Bois. 2001. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell Mol. Biol. 25:272-277.
51. Sato, H., J. C. Grutters, P. Pantelidis, A. N. Mizzon, T. Ahmad, A.-J. van Houte, J.-W. J. Lammers, J. M. M. van den Bosch, K. I. Welsh, and R. M. du Bois. 2002. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir Cell Mol. Biol. 27:406-412.
52. Naruse, T. K., Y. Matsuzawa, M. Ota, Y. Katsuyama, A. Matsumori, M. Hara, S. Nagai, S. Morimoto, S. Sasayama, and H. Inoko. 2000. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 56:52-57.
53. Grunewald, J., T. Hultman, A. Bucht, A. Eklund, and H. Wigzell. 1995. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol. Med. 1:287-296.
54. Grunewald, J., M. Berlin, O. Olerup, and A. Eklund. 2000. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 161:814-818.
55. Wahlstrom, J., K. Katchar, H. Wigzell, O. Olerup, A. Eklund, and J. Grunewald. 2001. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am. J. Respir. Crit. Care Med. 163:115-121.
56. Ziegenhagen, M. W., U. K. Benner, G. Zissel, P. Zabel, M. Schlaak, and J. Müller-Quernheim. 1997. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am. J. Respir. Crit. Care Med. 156:1586-1592.
57. Zissel, G., J. Homolka, J. Schlaak, M. Schlaak, and J. Muller-Quernheim. 1996. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 154:713-719.
58. Zorzetto, M., C. Bombieri, I. Ferrarotti, S. Medaglia, C. Agostini, C. Tinelli, G. Malerba, N. Carrabino, A. Beretta, L. Casali, E. Pozzi, P. F. Pignatti, G. Semenzato, M. C. Cuccia, and M. Luisetti. 2002. Complement receptor 1 gene polymorphisms in sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27:17-23.
59. Iannuzzi, M. C., M. Maliarik, and B. A. Rybicki. 2002. Nomination of a candidate susceptibility gene in sarcoidosis: the complement receptor 1 gene. Am. J. Respir. Cell Mol. Biol. 27:3-7.